已核实 DOI PubMed 相关产品: 226

Upconversion-mediated CRISPR-Cas12a biosensing for sensitive detection of ochratoxin A

Journal 2022 · IF 6.556 · 发表于 2022 年 1 月 21 日
作者: Zefeng Mao,Xiaojuan Wang,Ruipeng Chen,Zixuan Zhou,Shuyue Ren,Jun Liang,Zhixian Gao
阅读全文 在 PubMed 查看

摘要

The CRISPR-Cas system has achieved breakthrough applications in the field of molecular diagnostics. CRISPR/Cas12a can accurately identify subtle changes in a target nucleic acid sequence and has a wide range of applications such as in highly sensitive detection methods. In this study, an upconversion-magnetic probe-DNA-Fe 3 O 4 probe was designed to replace traditional fluorescent probes using nucleic acid aptamers to design a biosensing method powered by CRISPR/Cas12a. The CRISPR/Cas12a technology can be widely used for sensitive, rapid, and stable detection of ochratoxin A. In our sensing strategy, the ochratoxin A capture probe was used to capture ochratoxin A and release the Cas protein activation chain, further triggering the single-stranded DNA degradation activity of CRISPR/Cas12a and removal of the fluorescent probe to generate a fluorescent signal. Compared with traditional commercial kits, our method was more rapid and exhibited comparable detection capability.

本研究中使用的阿拉丁产品

226 款产品在本文中被引用